MRP1 but Not MDR1 Is Associated With Response to Neoadjuvant Chemotherapy in Breast Cancer Patients

Disease Markers - Egypt
doi 10.1155/2013/728410
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Hindawi Limited

Related search

RB-Pathway Disruption Is Associated With Improved Response to Neoadjuvant Chemotherapy in Breast Cancer

Clinical Cancer Research
Cancer ResearchOncology
2012English

Indoleamine-2,3-Dioxygenase and Interleukin-6 Associated With Tumor Response to Neoadjuvant Chemotherapy in Breast Cancer

Oncotarget
Oncology
2017English

Osteopontin and Vasculogenic Mimicry Formation Are Associated With Response to Neoadjuvant Chemotherapy in Advanced Breast Cancer

OncoTargets and Therapy
OncologyPharmacology
2017English

Prediction of Neoadjuvant Chemotherapy Response in Breast Cancer

Journal of Medical – Clinical Research & Reviews
2019English

HLA-DR in Cytotoxic T Lymphocytes Predicts Breast Cancer Patients' Response to Neoadjuvant Chemotherapy

Frontiers in Immunology
AllergyImmunology
2018English

P53 Codon 72 Polymorphism Predicts the Pathologic Response to Neoadjuvant Chemotherapy in Patients With Breast Cancer

Clinical Cancer Research
Cancer ResearchOncology
2005English

Correlation of Post-Neoadjuvant Chemotherapy Response on MRI With Final Histology in Breast Cancer Patients

Breast Cancer Research
Cancer ResearchOncology
2015English

Predictors of Recurrence in Breast Cancer Patients With a Pathologic Complete Response After Neoadjuvant Chemotherapy

British Journal of Cancer
Cancer ResearchOncology
2010English

Neoadjuvant Chemotherapy in Breast Cancer

English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy